#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "TDP-43 loss of function increases TFEB activity and blocks autophagosome–lysosome fusion"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Sandra Spalek"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/chebi-names.belns"
#DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/drugbank-names.belns"
#DEFINE NAMESPACE DOID           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/doid-names.belns"
#DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/ec-code.belns"
#DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/fb-names.belns"
#DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/export/hbp-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc.genefamily-names.belns"
#DEFINE NAMESPACE HP             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hp-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/go-names.belns"
#DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mesh-names.belns"
#DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
#DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mirbase-names.belns"
#DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/ncbigene.belns"
#DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/pfam-names.belns"
#DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
#DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
#DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
#DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
#DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
#DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
#DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
#DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
#DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
#DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
#DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
#DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
#DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
#DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
#DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "26702100"}

# ALP: Autophagy–lysosome pathway
# ALS: Amyotrophic lateral sclerosis

# in TDP-43-deficient cells

SET Evidence = "Given that ALP, the critical cellular quality control system, is
involved in ALS (Ling et al, 2013) and that TFEB is a master regulator
of ALP and is functionally associated with neurodegenerative
diseases as recently reported (Sardiello et al, 2009; Settembre et al,
2011; Tsunemi et al, 2012; Decressac et al, 2013; Spampanato et al,
2013), we wonder whether TDP-43 is able to regulate TFEB"
bp(GO:autophagy) -- path(MESH:"Amyotrophic Lateral Sclerosis")
p(HGNC:TFEB) reg bp(GO:autophagy)
p(HGNC:TFEB) -- path(MESH:"Neurodegenerative Diseases")

SET Evidence = "We observed that knockdown of TDP-43 resulted in a dramatic
increase of nuclear and a decrease of cytoplasmic GFP-tagged TFEB
in those cells (Fig 1A and B)."
# those cells: HeLa (non-neuronal) and SH-SY5Y (neuronal) cells
SET CellLine = {"HeLa cell","SH-SY5Y cell"}
p(HGNC:TARDBP) -| p(HGNC:TFEB,loc(GO:nucleus))
p(HGNC:TARDBP) -> p(HGNC:TFEB,loc(GO:cytoplasm))
UNSET CellLine

SET Evidence = "Based on the observations that mTORC1 plays an important role in
the regulation of TFEB (Pena-Llopis et al, 2011; Martina et al, 2012;
Roczniak-Ferguson et al, 2012; Settembre et al, 2012; Martina & Puertollano, 2013),
we hypothesized that TDP-43 may regulate TFEB nuclear translocation in an mTORC1-dependent manner"
p(HGNCGENEFAMILY:"MTOR complex 1") reg p(HGNC:TFEB)

# localization of mTOR reflects the activity of mTORC1

SET Evidence = "TDP-43-depleted cells showed a dramatic reduction of the
punctate mTOR distribution that could indicate its lysosomal localization
according to the previous reports (Fig 2A)."
p(HGNC:TARDBP) -> p(HGNC:MTOR),loc(GO:lysosome))
p(HGNC:TARDBP) -> act(p(HGNCGENEFAMILY:"MTOR complex 1"))

SET Evidence = "Furthermore, the activity of mTORC1 was suppressed after knockdown of TDP-43,
indicated by the phosphorylation of mTORC1 substrates p70S6K (Fig 2B)"
# p70S6K is RPS6KB1
# detected by using anti-phospho-p70S6K antibody (T389) [phosphorylation at T389]
p(HGNC:TARDBP) -> act(p(HGNCGENEFAMILY:"MTOR complex 1"))
p(HGNC:RPS6KB1,pmod(Ph,Thr,389)) neg act(p(HGNCGENEFAMILY:"MTOR complex 1"))
act(p(HGNCGENEFAMILY:"MTOR complex 1")) -- p(HGNC:RPS6KB1)

SET Evidence = "Given that amino acid is a well-established regulator of
mTORC1 and promotes mTOR translocation to the lysosomal
surface, we next examined the intracellular localization of mTOR
under starvation or re-addition of amino acids in cells after starvation
with or without TDP-43 knockdown"
a(CHEBI:"amino acid") reg act(p(HGNCGENEFAMILY:"MTOR complex 1"))
a(CHEBI:"amino acid") -> p(HGNC:MTOR),loc(GO:lysosome))

SET Evidence = "The enrichment of mTOR on lysosomes was impaired once
cells were starved, but was restored after amino acids re-feeding
(Fig 2C, upper panel)."
a(CHEBI:"amino acid") -> p(HGNC:MTOR),loc(GO:lysosome))
path(MESH:Starvation) -| p(HGNC:MTOR),loc(GO:lysosome))

SET Evidence = "Meanwhile, mTOR failed to localize to lysosomes
in TDP-43-depleted cells regardless of the presence or
absence of amino acids (Fig 2C, lower panel)."
p(HGNC:TARDBP) -> p(HGNC:MTOR),loc(GO:lysosome))

SET Evidence = "Consistent with these
data, biochemical assays showed that the level of phosphorylated
p70S6K was relatively low after starvation. Re-treatment of amino
acids failed to restore p70S6K phosphorylation in TDP-43-depleted
cells, whereas it significantly induced p70S6K phosphorylation in
control cells (Fig 2D)."
path(MESH:Starvation) -| p(HGNC:RPS6KB1,pmod(Ph,Thr,389))
a(CHEBI:"amino acid") -> p(HGNC:RPS6KB1,pmod(Ph,Thr,389))

SET Evidence = "Previous studies have shown that the subcellular localization and
activity of mTOR are highly controlled by mTORC1 adaptor protein
raptor, Rag GTPases, and Ragulator complex which is comprised of
p18, p14, and MP1 proteins that reside directly on the lysosomal
membrane surface (Sancak et al, 2008, 2010; Zoncu et al, 2011a;
Bar-Peled et al, 2012)."
p(HGNC:RPTOR) reg act(p(HGNC:MTOR))
p(UNIPROT:A0A074S494) reg act(p(HGNC:MTOR))
###################
complex(GO:"Ragulator complex") reg act(p(HGNC:MTOR))
complex(GO:"Ragulator complex") hasComponents list(p(HGNC:LAMTOR1),p(HGNC:LAMTOR2),p(HGNC:LAMTOR3))

SET Evidence = "In Ragulator–Rag–mTORC1 complex, Ragulator
anchors the Rag GTPases to lysosomes, which is essential for
Rag GTPases activation through an amino acids-dependent manner."
complex(a(GO:"Ragulator complex"),p(UNIPROT:A0A074S494),p(HGNCGENEFAMILY:"MTOR complex 1")) -> complex(Rag,a(GO:lysosome))
#####

SET Evidence = "Meanwhile, raptor interacts with active Rag GTPase heterodimers in
which GTP-bound RagA or RagB (very similar to RagA) associates
with GDP-bound RagC or RagD (similar to RagC), and raptor targets
mTOR to lysosome surface where mTOR could be activated by its
activator Rheb on the lysosomes."
complex(p(HGNC:RPTOR),p(HGNC:RRAGA),p(HGNC:RRAGC))
complex(p(HGNC:RPTOR),p(HGNC:RRAGA),p(HGNC:RRAGD))
complex(p(HGNC:RPTOR),p(HGNC:RRAGB),p(HGNC:RRAGC))
complex(p(HGNC:RPTOR),p(HGNC:RRAGB),p(HGNC:RRAGD))
p(HGNC:RPTOR) -> p(HGNC:MTOR,loc(GO:lysosome))
SET CellStructure = "Lysosomes"
p(HGNC:RHEB) -> act(p(HGNC:MTOR)
UNSET CellStructure

SET Evidence = "TDP-43-depleted cells showed a
decrease of raptor, but not mTOR, p18, and RagB, compared with
control cells (Fig 2B)"
p(HGNC:TARDBP) -> p(HGNC:RPTOR)

SET Evidence = "Downregulation of raptor
mRNA was observed in TDP-43-depleted cells, whereas mRNA
levels of other known members of mTOR-associated machinery on
the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP,
C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E
and EV1C)."
p(HGNC:TARDBP) -> r(HGNC:RPTOR)

SET Evidence = "The cells treated with siRNA against raptor had diminished
mTOR localization to lysosomes, showing a similarity to the
cells treated with siRNA against TDP-43 (Figs 2F and G, and EV1A and B)."
p(HGNC:RPTOR) -> p(HGNC:MTOR),loc(GO:lysosome))

SET Evidence = "Given that raptor is the key adaptor of mTORC1 and directly
regulates mTOR lysosomal localization, we wondered whether
TDP-43 regulates mTOR lysosomal localization in a raptor-dependent manner."
complex(p(HGNC:RPTOR),p(HGNCGENEFAMILY:"MTOR complex 1"))
p(HGNC:RPTOR) reg p(HGNC:MTOR),loc(GO:lysosome))

SET Evidence = "In TDP-43-depleted cells, mTOR was recruited to lysosomes,
indicated by a co-localization of lysosomal marker LAMP1
and CD63 after raptor re-transfection (Figs 2F and G, and EV1D and
E), suggesting a specific dependence of raptor in TDP-43-mediated
mTOR lysosomal localization"
p(HGNC:TARDBP) reg p(HGNC:MTOR),loc(GO:lysosome))
complex(p(HGNC:MTOR),p(HGNC:LAMP1))
complex(p(HGNC:MTOR),p(HGNC:CD63))
p(HGNC:LAMP1) -- a(GO:lysosome)
p(HGNC:CD63) -- a(GO:lysosome)

SET Evidence = "In contrast, in TDP-43 knockdown cells, TFEB and mTOR localization
was dramatically changed, showing that TFEB was translocated
from the cytosol to the nucleus and formed lysosomal puncta in
cytoplasm, whereas mTOR had a diffusively cytoplasmic distribution
(Figs 3A and EV2), suggesting an involvement of mTORC1 in
TDP-43-mediated TFEB nuclear translocation"
p(HGNC:TARDBP) -| p(HGNC:TFEB,loc(GO:nucleus))
p(HGNC:TARDBP) -> p(HGNC:TFEB,loc(GO:cytoplasm))
p(HGNCGENEFAMILY:"MTOR complex 1") -- act(p(HGNC:TARDBP))

SET Evidence = "After a restoration of raptor, but not active Rag
GTPases (RagAGTP/RagCGDP), TFEB shuttled back to the cytoplasm
(Figs 3A, EV2, and EV3A and B), suggesting a critical role of raptor
in TDP-43-mediated regulation of TFEB."
p(HGNC:RPTOR) -> tloc(p(HGNC:TFEB),fromLoc(GO:nucleus),toLoc(GO:nucleus))

SET Evidence = "Based on the studies that
Rag GTPases functions in the recruitment of TFEB and mTOR to
lysosomes (Martina & Puertollano, 2013), we next tested whether
TDP-43 could influence the lysosomal localization of Rag GTPases."
p(UBIPROT:A0A074S494) -> p(HGNC:TFEB,loc(GO:lysosome))
p(UBIPROT:A0A074S494) -> p(HGNC:MTOR,loc(GO:lysosome))

SET Evidence = "The enrichment of the active Rag GTPases (RagAGTP/RagCGDP)
(Martina & Puertollano, 2013) on lysosomes was not disturbed after
knockdown of TDP-43, but was strongly abolished after knockdown
of p18, which anchors Rag GTPases to lysosomes (Fig 3D), indicating
that loss of TDP-43 does not affect the localization of the Rag
GTPases."
p(HGNC:LAMTOR1) -> p(HGNC:RRAGA,loc(GO:lysosome))
p(HGNC:LAMTOR1) -> p(HGNC:RRAGC,loc(GO:lysosome))

SET Evidence = "The conversion of serine 211 to alanine in TFEB results in a loss
of phosphorylation of TFEB by mTORC1, which in turn blocks the
formation of the TFEB-14-3-3 complex in the cytosol, leading to a
constitutive nuclear localization, as well as an increased lysosomal
localization of TFEB (Martina et al, 2012; Roczniak-Ferguson et al,
2012; Martina & Puertollano, 2013)."
p(HGNC:TFEB,var("p.Ser211Ala")) -| p(HGNC:TFEB,pmod(Ph))
p(HGNCGENEFAMILY:"MTOR complex 1") -> p(HGNC:TFEB,pmod(Ph))
SET CellStructure = "Cytosol"
p(HGNC:TFEB,var("p.Ser211Ala")) -| complex(p(HGNC:TFEB),p(HGNCGENEFAMILY:"14-3-3 phospho-serine/phospho-threonine binding proteins"))
p(HGNC:TFEB,pmod(Ph)) -> complex(p(HGNC:TFEB),p(HGNCGENEFAMILY:"14-3-3 phospho-serine/phospho-threonine binding proteins"))
UNSET CellStructure

SET Evidence = "In contrast, TFEB-D30 mutant
(deletion of the first 30 amino acids) and TFEB-Q10A/L11A mutant
could not associate with Rag GTPases and lysosomes, leading to a
failure of phosphorylation of Ser211 by mTORC1 and subsequently
being transported easily into the nucleus (Martina et al, 2012;
Roczniak-Ferguson et al, 2012)."
p(HGNC:TFEB,var("p.1_30del")) -| complex(a(GO:lysosome),p(HGNC:TFEB),p(UNIPROT:A0A074S494))
p(HGNC:TFEB,var("p.1_30del")) -| p(HGNC:TFEB,pmod(Ph,Ser,211))
p(HGNC:TFEB,var("p.1_30del")) -> p(HGNC:TFEB,loc(GO:nucleus))
p(HGNC:TFEB,var("p.Gln10Ala"),var("p.Lys11Ala")) -| complex(a(GO:lysosome),p(HGNC:TFEB),p(UNIPROT:A0A074S494))
p(HGNC:TFEB,var("p.Gln10Ala"),var("p.Lys11Ala")) -| p(HGNC:TFEB,pmod(Ph,Ser,211))
p(HGNC:TFEB,var("p.Gln10Ala"),var("p.Lys11Ala")) -> p(HGNC:TFEB,loc(GO:nucleus))
complex(a(GO:lysosome),p(HGNC:TFEB),p(UNIPROT:A0A074S494)) -> p(HGNC:TFEB,pmod(Ph,Ser,211))
p(HGNCGENEFAMILY:"MTOR complex 1") -> p(HGNC:TFEB,pmod(Ph,Ser,211))

SET Evidence = "In our observations, knockdown of
TDP-43 significantly increased wild-type (WT) TFEB, but not TFEBD30
or TFEB-Q10A/L11A lysosomal localization (Figs 3E and EV3C
and D), suggesting that Rag GTPases, but not TDP-43, are critical
for the association of TFEB with lysosomes"
p(HGNC:TARDBP) -| p(HGNC:TFEB,loc(GO:lysosome))
p(HGNC:TARDBP) cnc p(HGNC:TFEB,var("p.1_30del"),loc(GO:lysosome))
p(HGNC:TARDBP) cnc p(HGNC:TFEB,var("p.Gln10Ala"),var("p.Lys11Ala"),loc(GO:lysosome))

SET Evidence = "In agreement with other studies (Martina
et al, 2012; Roczniak-Ferguson et al, 2012; Settembre et al, 2012;
Martina & Puertollano, 2013), TFEB was dramatically translocated
to the nuclei and lysosomes after the treatment of Torin-1, a specific
mTORC1 inhibitor."
a(CHEBI:"torin 1") isA a(CHEBI:"mTOR inhibitor")
a(CHEBI:"torin 1") -> p(HGNC:TFEB,loc(GO:lysosome))
a(CHEBI:"torin 1") -> p(HGNC:TFEB,loc(GO:nucleus))

SET Evidence = "In contrast, starvation or depletion of RagB led
to an increase of nuclear, but not lysosomal translocation of TFEB,
even if the cells were subsequently incubated with Torin-1 (Fig 3F)."
p(HGNC:RRAGB) -| p(HGNC:TFEB,loc(GO:nucleus))
p(HGNC:RRAGB) cnc p(HGNC:TFEB,loc(GO:lysosome))

SET Evidence = "The mRNA and protein levels of raptor were restored
upon re-expression with wild-type TDP-43 in TDP-43-deficient cells,
indicating a role of TDP-43 in the regulation of raptor gene expression
level (Fig 4A and B)."
p(HGNC:TARDBP) -> p(HGNC:RPTOR)
p(HGNC:TARDBP) -> r(HGNC:RPTOR)

SET Evidence = "In agreement with this, RNA immunoprecipitation
(RIP) analysis showed that wild-type TDP-43, but not the
RRM1 and RRM2 domain deletion mutant, could bind to raptor
mRNA (Fig 4E)."
complex(p(HGNC:TARDBP),r(HGNC:RPTOR))

SET Evidence = "Importantly, we observed that the mRNA stability
of raptor, but not RagB, was decreased in TDP-43-deficient cells
(Fig 4G and Appendix Fig S3)."
p(HGNC:TARDBP) -> act(r(HGNC:RPTOR))

SET Evidence = "As nuclear translocation of TFEB is associated with TFEB transcriptional
activity, which is tightly involved in the regulation of
lysosomal biogenesis and autophagic level, we wonder whether
TDP-43 could regulate ALP"
p(HGNC:TFEB,loc(GO:nucleus)) -- act(p(HGNC:TFEB), ma(GO:"nucleic acid binding transcription factor activity"))
act(p(HGNC:TFEB), ma(GO:"nucleic acid binding transcription factor activity")) reg a(GO:lysosome)
act(p(HGNC:TFEB), ma(GO:"nucleic acid binding transcription factor activity")) reg bp(GO:autophagy)

#Lysotracker (a specific lysosomal fluorescent probe) as a marker to monitor lysosomal biogenesis

SET Evidence = "In TDP-43-depleted cells, the fluorescent
intensity of Lysotracker was markedly increased (Fig 5A
and Appendix Fig S4A and B)."
p(HGNC:TARDBP) -| a(GO:lysosome)

SET Evidence = "TDP-43-depleted cells showed a global increase of
both mRNA and protein expression levels of a set of TFEB target
genes, including lysosomal and autophagic genes, such as genes
involved in lysosomal biogenesis and function (LAMP1, cathepsins,
and genes encoding subunits of vacuolar ATPases), and genes
involved in autophagy (ATG5, Beclin-1, and ATG9B; Fig 5B and C)."
p(HGNC:TARDBP) -| p(HGNC:LAMP1)
p(HGNC:TARDBP) -| r(HGNC:LAMP1)
p(HGNC:LAMP1) -- a(GO:lysosome)
p(HGNC:TARDBP) -| p(HGNCGENEFAMILY:Cathepsins)
p(HGNCGENEFAMILY:Cathepsins) -- a(GO:lysosome)
p(HGNC:TARDBP) -| a(MESH:"Vacuolar Proton-Translocating ATPases")
a(MESH:"Vacuolar Proton-Translocating ATPases") -- a(GO:lysosome)
p(HGNC:TARDBP) -| p(HGNC:ATG5)
p(HGNC:TARDBP) -| r(HGNC:ATG5)
p(HGNC:ATG5) -- bp(GO:autophagy)
p(HGNC:TARDBP) -| p(HGNC:BECN1)
p(HGNC:TARDBP) -| r(HGNC:BECN1)
p(HGNC:BECN1) -- bp(GO:autophagy)
p(HGNC:TARDBP) -| p(HGNC:ATG9B)
p(HGNC:TARDBP) -| r(HGNC:ATG9B)
p(HGNC:ATG9B) -- bp(GO:autophagy)

# LC3-II and the numbers of LC3-labeled vesicles reflect the autophagosome numbers

SET Evidence = "Consistent with these results,
immunofluorescent assay showed a dramatic increased punctuate
LC3 in the absence of TDP-43 (Fig EV4B and C)."
p(HGNC:TARDBP) -| a(GO:autophagosome)

SET Evidence = "Knockdown of
TDP-43 also increased punctuate p62 (an autophagic substrate and
marker protein) and LC3 that were co-localized in cells (Fig EV4D and E)."
p(HGNC:TARDBP) -| p(HGNC:SQSTM1)
p(HGNC:TARDBP) -| p(HGNC:MAP1LC3A)
complex(p(HGNC:MAP1LC3A),p(HGNC:SQSTM1))

SET Evidence = "Moreover, immunoblot and electron microscopy (EM) analyses
demonstrated that loss of TFEB could abolish the increases of
levels of LC3-II, autophagosomal, and lysosomal numbers in TDP-
43-depleted cells (Fig 6A and B)."
p(HGNC:TFEB) -> p(HGNC:MAP1LC3B)
p(HGNC:TFEB) -> a(GO:autophagosome)
p(HGNC:TFEB) -> a(GO:lysosome)

SET Evidence = "The level of LC3-II was also increased in TDP-43-
depleted cells treated with bafilomycin A1 compared with control
cells treated with bafilomycin A1 (Fig 6C), indicating that loss of
TDP-43 enhanced autophagosome synthesis"
a(CHEBI:"bafilomycin A1") -| act(complex(GO:"vacuolar proton-transporting V-type ATPase complex"))
p(HGNC:TARDBP) -| bp(GO:"autophagosome assembly")
p(HGNC:TARDBP) -| p(HGNC:MAP1LC3B)
a(CHEBI:"bafilomycin A1") -> p(HGNC:MAP1LC3B)

SET Evidence = "An significant
increase of autophagosomes (yellow dots with both mCherry and
EGFP signals) was observed in TDP-43-depleted cells compared
with control cells, but the formation of autolysosomes (red dots
with only mCherry signal since quenching of the EGFP signal in the
acidic lysosomes) was not enhanced to a same extent as autophagosomes
(Fig 6D and E)"
p(HGNC:TARDBP) -| a(GO:autophagosome)
p(HGNC:TARDBP) reg a(GO:autolysosome)

SET Evidence = "In addition, formation of autophagosomes
(yellow) was also enhanced in TDP-43-depleted cells treated
with bafilomycin A1 (Fig 6D and E)."
a(CHEBI:"bafilomycin A1") -> a(GO:autolysosome)
p(HGNC:TARDBP) reg a(GO:autolysosome)

SET Evidence = "Notably, under starvation
condition, we observed an increase of autophagosomes and a
decrease of autolysosomes in TDP-43-depleted cells compared
with control cells, suggesting that knockdown of TDP-43 could
impair autophagosome–lysosome fusion in a mTORC1-independent
manner, thereby inhibiting autophagic flux under starvation
condition (Fig 6D and E)."
path(MESH:Starvation) -> a(GO:autophagosome)
path(MESH:Starvation) -| a(GO:autolysosome)
p(HGNC:TARDBP) -> bp(GO:"autophagosome-lysosome fusion")

SET Evidence = "In supporting with this notion, the
protein level of autophagic substrate p62 was upregulated in TDP-
43-deficient cells under basal and starvation conditions (Fig 6G),
whereas the mRNA level of p62 was not changed in those cells
(Fig EV4F)."
p(HGNC:TARDBP) -| p(HGNC:SQSTM1)

SET Evidence = "Our results showed that the gene expression level of DCTN1, which
encodes dynactin 1, was significantly decreased in TDP-43-depleted
cells (Fig EV5A and B)."
p(HGNC:TARDBP) -> g(HGNC:DCTN1)

SET Evidence = "Furthermore, protein expression level of
dynactin 1, but not dynein heavy and intermediate chains (DHC and
DIC), was decreased in those cells (Fig 7A)."
p(HGNC:TARDBP) -> p(HGNC:DCTN1)
p(HGNC:TARDBP) cnc a(MESH:Dyneins)

SET Evidence = "Importantly,
we observed significant decreased LC3/LAMP1 co-localization
(autophagosome–lysosome fusion) in dynactin 1-deficient cells,
and loss of TDP-43 was not able to decrease LC3/LAMP1 co-localization
in dynactin 1-deficient cells (Fig 7D and E)."
p(HGNC:DCTN1) -> bp(GO:"autophagosome-lysosome fusion")

SET Evidence = "Meanwhile, retransfection
of dynactin 1 could increase LC3/LAMP1 co-localization
in TDP-43-depleted cells (Fig 7F and G), indicating that dynactin 1
deficiency contributes to the impairment of autophagosome–lysosome
fusion in TDP-43-depleted cells"
# LC3/LAMP1 co-localization (autophagosome–lysosome fusion)
p(HGNC:DCTN1) -> bp(GO:"autophagosome-lysosome fusion")

SET Evidence = "In TBPH-/- larvae, compared with
W1118 control larvae, the phosphorylation levels of S6K and
4E-BP1, but not expression of S6K mRNA, were decreased (Fig 8A
and D, and Appendix Fig S6A). Furthermore, the level of phosphorylated
S6K and 4E-BP1 was consistently decreased in the first-, second-, and third-instar TBPH
-/- larvae (Fig 8E)."
# TDP-43 depletion
# S6K is RPS6KB1
# 4E-BP1 is EIF4EBP1
SET Species = "7227"
p(HGNC:TARDBP) -> p(HGNC:EIF4EBP1,pmod(Ph))
p(HGNC:TARDBP) -> p(HGNC:RPS6KB1,pmod(Ph))
UNSET Species

SET Evidence = "As we have
shown that raptor is regulated by TDP-43 in cells, we therefore
examined the mRNA levels of raptor in W1118 and TBPH -/- larvae.
Similarly as the changes observed in TDP-43-depleted cells, the
expression levels of raptor were decreased (Fig 8B and C)."
SET Species = "7227"
p(HGNC:TARDBP) reg p(HGNC:RPTOR)
p(HGNC:TARDBP) -> p(HGNC:RPTOR)
UNSET Species

SET Evidence = "In addition, the expression level of lysosomal and autophagic genes
such as VhaSFD, CTSB, CathD, LAMP1, Sap-r, CG14291, and ATG6
was increased in TBPH-depleted adult flies (Fig 8I)."
# VhaSFD is ATP6V1H
# CathD is CTSD
# CG14291 is SGSH
# ATG6 is BECN1
SET Species = "7227"
p(HGNC:TARDBP) -| g(HGNC:ATP6V1H)
p(HGNC:TARDBP) -| g(HGNC:CTSB)
p(HGNC:TARDBP) -| g(HGNC:CTSD)
p(HGNC:TARDBP) -| g(HGNC:LAMP1)
p(HGNC:TARDBP) -| g(HGNC:PSAP)
p(HGNC:TARDBP) -| g(HGNC:SGSH)
p(HGNC:TARDBP) -| g(HGNC:BECN1)
UNSET Species

SET Evidence = "In addition, EM
analysis showed a significant blockage of autophagosome–lysosome
fusion in starved TBPH -/- larvae (Appendix Fig S5)."
SET Species = "7227"
p(HGNC:TARDBP) -> bp(GO:"autophagosome-lysosome fusion")
UNSET Species
